Medicamen Biotech Board to Consider Q2 FY27 Results on 13th Nov'26
Medicamen Biotech Ltd 路 Intimation 路 13 Nov 2026, 5:30 am
Medicamen Biotech Board to Consider Q2 FY27 Results on 13th Nov'26 Medicamen Biotech Limited announced that its Board of Directors will meet on 13th Nov'26 to consider and approve standalone and consolidated unaudited financial results for the quarter and half year ended 30th Sep'26. Per insider trading regulations, the trading window for dealing in company securities has been closed for designated persons since 1st Oct'26 and will reopen 48 hours after the declaration of the financial results to stock exchanges.
Original exchange filing (PDF)
More announcements from Medicamen Biotech Ltd
- Medicamen Biotech Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 13 Nov 2026
- Financial Results - Quarter and Half year ended on September 30, 2026 路 13 Nov 2026
- MEDICAMEN BIOTECH LIMITED has informed the Exchange about Board Meeting to be held on 13-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 13 Nov 2026
- MEDICAMEN BIOTECH LIMITED has informed the Exchange about Board Meeting to be held on 13-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 13 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 路 13 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shivalik Rasayan Ltd & Growel Remedies Ltd 路 26 Oct 2026
- Outcome of the meeting of Preferential Issue Commitee of the Board of Directors of Medicamen Biotech Limited to consider and approve the allotmentb of 5,00,000 Equity Shares pursuant to .... 路 23 Oct 2026
- Trading Plan under SEBI (PIT) Regulations 2015 - Mr Sanjay Bansal 路 30 Sept 2026
